These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 34089357)
1. COVID-19 in patients with gout on colchicine. Pelechas E; Drossou V; Voulgari PV; Drosos AA Rheumatol Int; 2021 Aug; 41(8):1503-1507. PubMed ID: 34089357 [TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature. Mansouri N; Marjani M; Tabarsi P; von Garnier C; Mansouri D Immunol Invest; 2021 Nov; 50(8):884-890. PubMed ID: 32633162 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review. Nas K; Eryilmaz N; Geyik MF; Altaş A Rheumatol Int; 2021 Apr; 41(4):811-817. PubMed ID: 33611657 [TBL] [Abstract][Full Text] [Related]
4. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study. Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043 [TBL] [Abstract][Full Text] [Related]
5. The development of a targeted and more potent, anti-Inflammatory derivative of colchicine: Implications for gout. Paré G; Vitry J; Marceau F; Vaillancourt M; Winter P; Bachelard H; Naccache PH; Tuszynski JA; Fernandes MJ Biochem Pharmacol; 2020 Oct; 180():114125. PubMed ID: 32598947 [TBL] [Abstract][Full Text] [Related]
6. Colchicine Against SARS-CoV-2 Infection: What is the Evidence? Drosos AA; Pelechas E; Drossou V; Voulgari PV Rheumatol Ther; 2022 Apr; 9(2):379-389. PubMed ID: 35107804 [TBL] [Abstract][Full Text] [Related]
7. Colchicine in the management of Covid-19: With or lieu of evidence. Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235 [TBL] [Abstract][Full Text] [Related]
8. The impact of COVID-19 on familial Mediterranean fever: a nationwide study. Günendi Z; Yurdakul FG; Bodur H; Cengiz AK; Uçar Ü; Çay HF; Şen N; Keskin Y; Gürer G; Melikoğlu MA; Altıntaş D; Deveci H; Baykul M; Nas K; Çevik R; Karahan AY; Toprak M; Ketenci S; Nayimoğlu M; Sezer İ; Demir AN; Ecesoy H; Duruöz MT; Yurdakul OV; Sarıfakıoğlu AB; Ataman Ş Rheumatol Int; 2021 Aug; 41(8):1447-1455. PubMed ID: 34032894 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of colchicine in the treatment of gout. Dalbeth N; Lauterio TJ; Wolfe HR Clin Ther; 2014 Oct; 36(10):1465-79. PubMed ID: 25151572 [TBL] [Abstract][Full Text] [Related]
10. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19? Nasiripour S; Zamani F; Farasatinasab M J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400 [No Abstract] [Full Text] [Related]
11. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients. Montealegre-Gómez G; Garavito E; Gómez-López A; Rojas-Villarraga A; Parra-Medina R Reumatol Clin (Engl Ed); 2021; 17(7):371-375. PubMed ID: 34301378 [TBL] [Abstract][Full Text] [Related]
12. [Colchicine: old medication with new benefits : Use in rheumatology and beyond]. Boyadzhieva Z; Ruffer N; Krusche M Z Rheumatol; 2021 Sep; 80(7):647-657. PubMed ID: 34097101 [TBL] [Abstract][Full Text] [Related]
13. Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient. Grgurevic L; Novak R; Hrkac S; Salai G; Grazio S Rheumatol Int; 2021 Aug; 41(8):1495-1501. PubMed ID: 34110466 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
15. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects. Al-Kuraishy HM; Al-Gareeb AI; Qusty N; Cruz-Martins N; El-Saber Batiha G Pulm Pharmacol Ther; 2021 Apr; 67():102008. PubMed ID: 33727066 [TBL] [Abstract][Full Text] [Related]
16. The role of colchicine in the management of COVID-19: a Meta-analysis. Elshiwy K; Amin GEE; Farres MN; Samir R; Allam MF BMC Pulm Med; 2024 Apr; 24(1):190. PubMed ID: 38641775 [TBL] [Abstract][Full Text] [Related]
17. Treating COVID-19 with colchicine in community healthcare setting. Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478 [No Abstract] [Full Text] [Related]
18. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City. Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850 [TBL] [Abstract][Full Text] [Related]
19. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis. Golpour M; Mousavi T; Alimohammadi M; Mosayebian A; Shiran M; Alizadeh Navaei R; Rafiei A Int J Immunopathol Pharmacol; 2021; 35():20587384211031763. PubMed ID: 34250834 [TBL] [Abstract][Full Text] [Related]
20. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Vitiello A; Ferrara F Respir Med; 2021 Mar; 178():106322. PubMed ID: 33550151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]